Shanghai MicuRx Pharmaceutical Co (688373)

Currency in CNY
7.93
-0.03(-0.38%)
Closed·
688373 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
688373 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.507.96
52 wk Range
3.688.80
Key Statistics
Bid/Ask
7.92 / 7.93
Prev. Close
7.96
Open
7.75
Day's Range
7.5-7.96
52 wk Range
3.68-8.8
Volume
20.15M
Average Volume (3m)
17.68M
1-Year Change
91.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688373 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Shanghai MicuRx Pharmaceutical Co Company Profile

Shanghai MicuRx Pharmaceutical Co., Ltd., a biopharmaceutical company, discovers, develops, and commercialize drugs for unmet medical needs. It is developing Contezolid (MRX-I) and Contezoilid acefosamil (MRX-4) oxazolidinone antibiotics for multidrug-resistant gram-positive bacteria; MRX-8 MRX, a polymyxin antibiotic, to target multidrug-resistant Gram-negative bacteria; MRX-5 for multidrug-resistant gram-negative bacteria; MRX-7 for multidrug-resistant gram-positive bacteria; MRX-15 and MRX-17 to treat kidney disease; MRX-18 for the treatment of COVID-19; and MRX-23 for the treatment of tumour. Shanghai MicuRx Pharmaceutical Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Employees
188
Market
China

Compare 688373 to Peers and Sector

Metrics to compare
688373
Peers
Sector
Relationship
P/E Ratio
−13.0x−29.6x−0.5x
PEG Ratio
−0.850.350.00
Price/Book
13.5x8.2x2.6x
Price / LTM Sales
39.8x21.1x3.3x
Upside (Analyst Target)
−34.4%1.1%40.3%
Fair Value Upside
Unlock−20.7%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.09 / --
Revenue / Forecast
33.22M / --
EPS Revisions
Last 90 days

688373 Income Statement

FAQ

What Stock Exchange Does Shanghai MicuRx Pharmaceutical Trade On?

Shanghai MicuRx Pharmaceutical is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai MicuRx Pharmaceutical?

The stock symbol for Shanghai MicuRx Pharmaceutical is "688373."

What Is the Shanghai MicuRx Pharmaceutical Market Cap?

As of today, Shanghai MicuRx Pharmaceutical market cap is 5.20B.

What Is Shanghai MicuRx Pharmaceutical's Earnings Per Share (TTM)?

The Shanghai MicuRx Pharmaceutical EPS (TTM) is -0.60.

When Is the Next Shanghai MicuRx Pharmaceutical Earnings Date?

Shanghai MicuRx Pharmaceutical will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 688373 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Shanghai MicuRx Pharmaceutical Stock Split?

Shanghai MicuRx Pharmaceutical has split 0 times.

How Many Employees Does Shanghai MicuRx Pharmaceutical Have?

Shanghai MicuRx Pharmaceutical has 188 employees.

What is the current trading status of Shanghai MicuRx Pharmaceutical (688373)?

As of 16 Aug 2025, Shanghai MicuRx Pharmaceutical (688373) is trading at a price of 7.93, with a previous close of 7.96. The stock has fluctuated within a day range of 7.50 to 7.96, while its 52-week range spans from 3.68 to 8.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.